Grupo Español De Enfermedades Mieloproliferativas Crónicas Ph Negativas

This study is testing if the drug pacritinib can reduce harmful scarring (fibrosis) in the bone marrow of patients with myelofibrosis, a type of blood cancer, who also have low platelet counts. It will involve about 30 patients who will take the drug for up to two years. Research…